The researchers hope the projects will lead to new avenues for treatments to help patients with conditions like COPD, pulmonary fibrosis, and acute respiratory distress syndrome.
Chronic viral infections and cancer can cause “killer” T cells in the immune system to take on a state of dysfunction or exhaustion whereby they can no longer react to infectious invaders or abnormal cells like normal “memory” T cells.
In recovered COVID-19 patients, SARS-CoV-2-specific CD8+ T-cell responses remained largely intact and could recognize virtually all mutations in the variants studied.
A new study suggests that T-cell immunity against the coronavirus is likely to be present six months after infection.
Read More
People of all ages can get sick from SARS-CoV-2, the virus that causes COVID-19. But the severity of the illness tends to worsen the older the patient is.
Read More
A recent research study adds evidence to the idea that in some patients, preventing dysregulated immune system responses may be as important as treating the virus itself.
Read More
Scientists have developed a new tool that mimics how SARS-CoV-2 infects a cell, information that could potentially speed the search for treatments against the disease.
Read More
Wildfire smoke can irritate the lungs and harm the immune system, making people more susceptible to COVID-19, reports WebMD.
Read More
A Johns Hopkins study found that strains of a subtype of H3N2 have a mutation that blocks antibodies from binding to a key viral protein.
Read More